Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Guzman

Showing results (631-640 of 682) with videos related to

Pageof 69
Sort By:
Plos Pathogens|January 13, 2022
Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infectionAaqib Sohail, Azeem A Iqbal, Nishika Sahini, et al.
ASN Neuro|October 23, 2015
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis PatientsAnn J Ligocki, Jacqueline R Rivas, William H Rounds, et al.
Plos Pathogens|November 29, 2022
Correction: Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infectionAaqib Sohail, Azeem A Iqbal, Nishika Sahini, et al.
Frontiers in Neurology|June 10, 2022
Neuropathology of Pediatric SARS-CoV-2 Infection in the Forensic Setting: Novel Application of <i>Ex Vivo</i> Imaging in Analysis of Brain MicrovasculatureMichelle N Stram, Alan C Seifert, Etty Cortes, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Frontiers in Cell and Developmental Biology|June 9, 2025
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Neurobiology of Aging|June 24, 2010
Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's diseaseBecky Inkster, Anil W Rao, Khanum Ridler, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMVAnusara Daenthanasanmak, Gustavo Salguero, Bala Sai Sundarasetty, et al.
Rheumatology (Oxford, England)|March 6, 2012
Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohortGuillermo J Pons-Estel, Graciela S Alarcón, Leticia Hachuel, et al.
Pediatrics|June 5, 2021
Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 VaccinationMayme Marshall, Ian D Ferguson, Paul Lewis, et al.
Pageof 69

Showing results (631-640 of 682) with videos related to

Sort By:
Pageof 69
Plos Pathogens|January 13, 2022
Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infectionAaqib Sohail, Azeem A Iqbal, Nishika Sahini, et al.
ASN Neuro|October 23, 2015
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis PatientsAnn J Ligocki, Jacqueline R Rivas, William H Rounds, et al.
Plos Pathogens|November 29, 2022
Correction: Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infectionAaqib Sohail, Azeem A Iqbal, Nishika Sahini, et al.
Frontiers in Neurology|June 10, 2022
Neuropathology of Pediatric SARS-CoV-2 Infection in the Forensic Setting: Novel Application of <i>Ex Vivo</i> Imaging in Analysis of Brain MicrovasculatureMichelle N Stram, Alan C Seifert, Etty Cortes, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Frontiers in Cell and Developmental Biology|June 9, 2025
Cell-based high-content approach for SARS-CoV-2 neutralization identifies unique monoclonal antibodies and PI3K pathway inhibitorsCarly R Cabel, Briana A Guzman, Elaheh Alizadeh, et al.
Neurobiology of Aging|June 24, 2010
Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's diseaseBecky Inkster, Anil W Rao, Khanum Ridler, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMVAnusara Daenthanasanmak, Gustavo Salguero, Bala Sai Sundarasetty, et al.
Rheumatology (Oxford, England)|March 6, 2012
Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohortGuillermo J Pons-Estel, Graciela S Alarcón, Leticia Hachuel, et al.
Pediatrics|June 5, 2021
Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 VaccinationMayme Marshall, Ian D Ferguson, Paul Lewis, et al.
Pageof 69